Johnson & Johnson’s $2.2 billion settlement to resolve False Claims Act allegations that it paid doctors kickbacks and promoted some drugs for off-label uses may be one of the last high-dollar settlements in the federal government’s long-running campaign to stop drug companies from marketing drugs for uses in which they are not approved. Johnson & Johnson was ordered to pay the 10-figure settlement based on illegal marketing of three of its drugs including the antipsychotic Risperdal, the schizophrenia drug Invega, and the cardiac drug Natrecor. The practice, attorneys said, put fragile patients – such as the elderly and children – ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.